(600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Share Repurchase Plan through Call Auction
Filed with SSE · Stock code 600518 · · 7 pages · Chinese
Kangmei Pharmaceutical Co., Ltd on 6ix
Story so far
Earlier from Kangmei Pharmaceutical
- Announcement on Resolutions of the 6th Extraordinary Meeting of the 10th Board of Directors in 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Progress of Litigation Involved (II)
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
- Announcement on Progress in Litigation Involved
Later from Kangmei Pharmaceutical
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress of Litigation Involved (III)
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares
- (600518)"Kangmei Pharmaceutical Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Holding Unrestricted Shares Concerning Share Repurchase
Follow Kangmei Pharmaceutical into a list and get an email when it puts out news.
Follow Kangmei Pharmaceutical